View Clinical Trial (Medical Research Study)
ACT-128800 in Relapsing-remitting Multiple Sclerosis - NCT01006265-(Clinical Trial 399049)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Tuscon |
|
State:
|
|
AZ |
| Zip Code: |
|
|
| Conditions: |
|
Relapsing-Remitting Multiple Sclerosis |
| Purpose: |
|
This study will assess the efficacy, safety, and tolerability of ACT-128800 in patients with
relapsing-remitting multiple sclerosis.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Adult males and females
- Diagnosis of RRMS as defined by the revised (2005) McDonald Diagnostic Criteria for
Multiple Sclerosis (MS).
- Signed inform consent prior to initiation of any study-mandated procedure.
Exclusion Criteria:
- A diagnosis of MS categorized as primary progressive or secondary progressive or
progressive relapsing.
- Patients currently treated for an autoimmune disorder other than MS.
- Contraindications for MRI.
- Ongoing bacterial, viral, or fungal infection.
- History or presence of malignancy.
Additional inclusion and exclusion criteria apply with respect to medical conditions and
concomitant treatments which could affect patients' risk from participating in the study. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 2, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|